Literature DB >> 15809904

Viral dynamics of primary HIV-1 infection in Senegal, West Africa.

Abdoulaye Dieng Sarr1, Geoffrey Eisen, Aissatou Guèye-Ndiaye, Christopher Mullins, Ibrahima Traoré, Mamadou Ciré Dia, Jean-Louis Sankalé, Diegane Faye, Souleymane Mboup, Phyllis Kanki.   

Abstract

BACKGROUND: Few studies have addressed primary human immunodeficiency virus (HIV) type 1 infection in sub-Saharan Africa, where the epidemic is of a predominantly heterosexual character and is caused by different subtypes. The present study examines the dynamics of viral replication in subjects infected with various HIV-1 subtypes.
METHODS: Seven hundred fifty-two HIV-negative Senegalese women at high risk for infection were monitored every 3 months for acute/early HIV infection; 26 infections were identified (23 HIV-1 and 3 HIV-2), with an HIV-1 incidence rate of 3.23 cases/person-years observation. Multiple viral-load measurements were taken for all seroconverters.
RESULTS: The mean+/-standard deviation viral load for all subjects during the early stage of infection was 4.13+/-0.66 log10 copies/mL, with an overall decrease of 0.22 log10 copies/mL after the early stage; the viral set point was reached after 12 months of infection. Most subjects had relatively low viral loads during the early stage of infection. HIV-1 CRF02_AG-infected women had a significantly higher mean viral load during the early stage of infection (mean +/- SD, 4.45+/-0.60 log(10) copies/mL) than did non-HIV-1 CRF02_AG-infected women (mean+/-SD, 3.78+/-0.46 log(10) copies/mL) (P=.008). None of the subjects reported symptoms consistent with primary HIV-1 infection.
CONCLUSION: Our findings in Senegalese women differ from what have been described for primary HIV-1 infection. Further investigations of primary infections with non-B subtypes are warranted, to better characterize their differences with primary infections with subtype B.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15809904     DOI: 10.1086/429409

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Molecular epidemiology of HIV type 1 CRF02_AG in Cameroon and African patients living in Italy.

Authors:  Nazle Mendonca Collaço Véras; Maria Mercedes Santoro; Rebecca R Gray; Andrew J Tatem; Alessandra Lo Presti; Flaminia Olearo; Giulia Cappelli; Vittorio Colizzi; Desiré Takou; Judith Torimiro; Gianluca Russo; Annapaola Callegaro; Romina Salpini; Roberta D'Arrigo; Carlo-Federico Perno; Maureen M Goodenow; Massimo Ciccozzi; Marco Salemi
Journal:  AIDS Res Hum Retroviruses       Date:  2011-05-06       Impact factor: 2.205

2.  Changes in soluble factor-mediated CD8+ cell-derived antiviral activity in cynomolgus macaques infected with simian immunodeficiency virus SIVmac251: relationship to biological markers of progression.

Authors:  Vincent Dioszeghy; Kadija Benlhassan-Chahour; Benoit Delache; Nathalie Dereuddre-Bosquet; Celine Aubenque; Gabriel Gras; Roger Le Grand; Bruno Vaslin
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

3.  Screening for acute HIV infection in South Africa: finding acute and chronic disease.

Authors:  I V Bassett; S Chetty; J Giddy; S Reddy; K Bishop; Z Lu; E Losina; K A Freedberg; R P Walensky
Journal:  HIV Med       Date:  2011-01       Impact factor: 3.180

4.  Viral and host factors associated with the HIV-1 viral load setpoint in adults from Mbeya Region, Tanzania.

Authors:  Elmar Saathoff; Michael Pritsch; Christof Geldmacher; Oliver Hoffmann; Rebecca N Koehler; Leonard Maboko; Lucas Maganga; Steffen Geis; Francine E McCutchan; Gustavo H Kijak; Jerome H Kim; Miguel A Arroyo; Martina Gerhardt; Sodsai Tovanabutra; Merlin L Robb; Carolyn Williamson; Nelson L Michael; Michael Hoelscher
Journal:  J Acquir Immune Defic Syndr       Date:  2010-07       Impact factor: 3.731

5.  Viral load and CD4+ T-cell dynamics in primary HIV-1 subtype C infection.

Authors:  Vladimir Novitsky; Elias Woldegabriel; Lemme Kebaabetswe; Raabya Rossenkhan; Busisiwe Mlotshwa; Caitlin Bonney; Mariel Finucane; Rosemary Musonda; Sikhulile Moyo; Carolyn Wester; Erik van Widenfelt; Joseph Makhema; Stephen Lagakos; M Essex
Journal:  J Acquir Immune Defic Syndr       Date:  2009-01-01       Impact factor: 3.731

6.  Dynamics of T-cell responses and memory T cells during primary simian immunodeficiency virus infection in cynomolgus macaques.

Authors:  Ingrid Karlsson; Benoît Malleret; Patricia Brochard; Benoît Delache; Julien Calvo; Roger Le Grand; Bruno Vaslin
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

7.  The evolution of HIV-1 group M genetic variability in Southern Cameroon is characterized by several emerging recombinant forms of CRF02_AG and viruses with drug resistance mutations.

Authors:  Lucy Agyingi; Luzia M Mayr; Thompson Kinge; George Enow Orock; Johnson Ngai; Bladine Asaah; Mbida Mpoame; Indira Hewlett; Phillipe Nyambi
Journal:  J Med Virol       Date:  2013-11-19       Impact factor: 2.327

8.  The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness.

Authors:  Harr F Njai; Youssef Gali; Guido Vanham; Claude Clybergh; Wim Jennes; Nicole Vidal; Christelle Butel; Eitel Mpoudi-Ngolle; Martine Peeters; Kevin K Ariën
Journal:  Retrovirology       Date:  2006-07-03       Impact factor: 4.602

9.  The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion.

Authors:  Deborah Donnell; Eric Ramos; Connie Celum; Jared Baeten; Joan Dragavon; Jordan Tappero; Jairam R Lingappa; Allan Ronald; Kenneth Fife; Robert W Coombs
Journal:  AIDS       Date:  2017-09-10       Impact factor: 4.177

10.  Epigenetics, N-myrystoyltransferase-1 and casein kinase-2-alpha modulates the increased replication of HIV-1 CRF02_AG, compared to subtype-B viruses.

Authors:  Biju Bhargavan; Georgette D Kanmogne
Journal:  Sci Rep       Date:  2019-07-23       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.